INSR and endometrial cancer: There is evidence for a direct effect on endometrial cancer cells of insulin and IGF-1; activation of the insulin receptor causes an increase in cell proliferation and inhibition of apoptosis [76,80,81] through both the MAPK and PI3K/Akt pathways.